Flavoring your lemonade with lavender is a great way to utilize the amazing medicinal properties of lavender. Lavender is a wonderful aromatic herb that calms the senses.
Pure lavender oil is an incredible essential oil to use for your own health and wellness. It’s among the gentlest of essential oils, but also one of the most powerful, making it a favorite of households for the healing properties and uses of lavender essential oil. Lavender oil has a chemically complex structure with over 150 active constituents, which explains its effectiveness at helping with a lot of health ailments.
Lavender oil possesses amazing anti-inflammatory, anti-fungal, antidepressant, antiseptic, antibacterial, antimicrobial, antispasmodic, analgesic, detoxifier, hypotensive, and sedative properties.
Florida researchers have found that lavender oil benefits include reducing anxiety and lowering pulse rates in nursing students taking stressful tests. And in hospital settings, lavender aromatherapy has been demonstrated to decrease pre-surgery distress and to be more relaxing than massage or merely resting.
Lavender essential oil has medicinal properties as well. It has been shown to reduce depression, improve insomnia and ease labor pains. And anecdotal evidence suggests that lavender oil benefits those with headaches, hangovers, sinus congestion and pain relief.
“Much prior research on lavender has focused on the administration of lavender via an olfactory route. The anxiolytic activity of lavender olfaction has been demonstrated in several small and medium-sized clinical trials.
The efficacy of aromatherapy of lavender is thought to be due to the psychological effects of the fragrance combined with physiological effects of volatile oils in the limbic system.
These calming effects of lavender oil and single constituents may be the origin of the traditional use of lavender. Lavender oil olfaction has been shown to decrease anxiety, as measured by the Hamilton rating scale, and can increase mood scores.
The following are selected examples of clinical trials on lavender aromatherapy
Dunn and colleagues demonstrated anxiolytic activity of lavender oil aromatherapy in patients in intensive care units. Subjects received at least 1 session of aromatherapy with 1% lavender essential oil. Significant anxiolytic effects were noted in the 1st treatment, though 2nd and 3rd treatments did not appear to be as effective.
Alaoui-Ismaili and colleagues found that the aroma of lavender is considered by subjects to be very pleasant and is correlated with changes in the autonomic nervous system.
Tysoe and colleagues conducted a study of lavender oil in burner use on staff mood and stress in a hospital setting. A significant number of respondents (85%) believed that lavender aroma improved the work environment following the use of the lavender oil burners.
Diego and colleagues demonstrated that people receiving lavender oil (10%) olfaction for 3 minutes felt significantly more relaxed and had decreased anxiety scores, improved mood and increased scores of alpha power on EEG (an indicator of alertness), and increased speed of mathematical calculations.
The effects of aromatherapy were measured using the Hamilton rating scale for depression (HAMD) and the Hamilton rating scale for anxiety (HAMA). Lavender aroma significantly decreased the mean scores of HAMA, suggesting an effective, noninvasive means for the treatment of anxiety in hemodialysis patients.
Lavender aromatherapy, with or without massage, may also reduce the perception of pain and the need for conventional analgesics in adults and children, though more rigorously controlled trials are needed.″
Simple Lavender Lemonade Recipe
1 cup raw honey
12 cups pure water
6 lemons, peeled and juiced
Lavender sprigs for garnish (optional)
Mix all ingredients together and chill. Add more water or raw honey if needed.
Mix 5 to 6 drops of to your bath water if you have dry skin.
Diffuse 10 to 12 drops of into the air during your workday for natural stress relief.
Add 2 drops of per ounce of your favorite lightly scented, unrefined organic oil (like almond oil or olive oil) for a body oil with all the benefits of lavender for improving your skin, relaxing your mind, warding off insects or helping you sleep.
4. Bandelow B, Zohar J, Hollander E, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders-first revision. World J Biol Psychiatry. 2008;9:248-312.
5. Longo LP, Johnson B. Addiction: Part I. Benzodiazepines—side effects, abuse risk and alternatives. Am Fam Physician. 2000;61:2121-2128.
6. Preskorn SH . Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 5;56 (Suppl 6):12-21.
7. Trindade E, Menon D, Topfer LA, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ. 1998;159:1245-1252.
9. Piscopo G. Kava kava: Gift of the islands. Alt Med Rev. 1997;2:355-381 .
10. Lehmann EE, Kinzler J, Friedmann J. Efficacy of a special kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin. A double-blind placebo-controlled study of four weeks treatment. Phytomedicine 1996;3:113-119.
11. Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders. A randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1-5.
12. Warnecke G. Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of kava extract WS 1490. Fortschr Med. 1991;119-122 .
14. Harrer G, Sommer H. Treatment of mild/moderate depressions with Hypericum. Phytomedicine. 1994;1:3-8.
15. Ernst E. St. John’s wort, an antidepressant? A systemic, criteria-based review. Phytomedicine. 1995;2:67-71.
16. Kasper S, Anghelescu IG, Szegedi A, et al. Superior efficacy of St John’s wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial . BMC Med. 2006;4:14.
17. Vorbach EU, Arnoldt KH, Hübner WD. Efficacy and tolerability of St. John’s wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry. 1997;30(suppl):81-85.
18. Vorbach EU, Hübner WD, Arnoldt KH. Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine: Randomized double-blind study with 135 outpatients. J Geriatr Psychiatry Neurol. 1994;7(suppl):S19-23.
19. Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomized multicenter study of treatment for eight weeks. BMJ. 1999;319:1534-1539.
20. Schrader D. Equivalence of St. John’s wort extract (ZE 117) and fluoxetine: a randomized, controlled study in mild–moderate depression. Int Clin Psychopharmacol. 2000;15:61-68.
21. Woelk H. Comparison of St. John’s wort and imipramine for treating depression: Randomized controlled trial. BMJ. 2000;321:536-569.
22. Wheatley D. LI 160, an extract of St. John’s wort versus amitriptyline in mildly to moderately depressed outpatients—controlled six week clinical trial. Pharmacopsychiatry. 1997;30(suppl):77-80.
24. Harrer G, Hübner WD, Poduzweit H. Effectiveness and tolerance of the Hypericum extract LI 160 compared to maprotiline: A multicenter double-blind study. J Geriatr Psychiatry Neurol. 1994;7(suppl 1);S24-S28.
25. Harrer G, Schmidt U, Kuhn U, Biller A. Comparison of equivalence between the St. John’s wort extract LoHyp-57 and fluoxetine. Arzneimittelforschung. 1999;49:289-296.
26. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John’s Wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287:1807-1814.
27. Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St John’s wort in major depression: a randomized controlled trial. JAMA. 2001;285:1978-1986.
28. Stafford N. Germany may ban kava kava herbal supplement. Reuters, Nov. 19, 2001.
29. Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with kava, a herbal remedy for anxiety. BMJ. 2001;322:139.
30. Kraft M, Spahn TW, Menzel J, et al. Fulminant liver failure after administration of the herbal antidepressant Kava-Kava. Dtsch Med Wochenschr. 2001;126:970-972 .
31. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr. 1998;123:1410-1414 .
32. Russmann S, Lauterburg BH, Helbling A. Kava hepatotoxicity. Ann Intern Med. 2001;135:68-69 .
33. Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John’s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA. 2003;290:1500-1504.
34. Greive M. A Modern Herbal. New York, Harcourt, Brace & Co., 1931.
35. Basch E, Foppa I, Liebowitz R, et al. Lavender (Lavandula angustifolia Miller). J Herb Pharmacother. 2004;4(2):63-78.
36. Blumenthal M, ed. Lavender flower. In: The Complete German Commission E Monographs. Austin, TX, American Botanical Council, 1998:159-160.
37. Cavanagh HMA, Wilkinson JM. Biological activities of lavender essential oil. Phytother Res 2002;16;301-308.
38. European Pharmacopoeia, 6th edition, 2008.
39. . Lavadulae Flos. Lavandulae Aetheroleum. (Lavender Flower. Lavender Oil). ESCOP Monographs. The Scientific Foundation for Herbal Medicine Products, 2nd ed. Supplement. New York and Stuttgart, Thieme, 2009:147-156.
40. Aoshima H, Hamamoto K. Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncid. Biosc Biotechnol Biochem 1999; 63:743-748.
41. Lis-Balchin M, Hart S. Studies on the mode of action of the essential oil of lavender. Phytother Res 1999;13(6):540-542.
42. Elizabetsky E, al Mje. Effects of linalool on glutamatergic system in the rat cerebral cortex. Neurochem Res 1995;20:461-465.
43. Re L, Barocci S, Sonnino S, et al. Linalool modifies the nicotinic receptor-ion channel kinetics at the mouse neuromuscular junction. Pharmacol Res. 2000;42:177-182.
44. Tisserand R, Balacs T. Essential oil safety. A Guide for Health Care Professionals. Harcourt 1999: Glasgow.
45. Buchbauer G, Jirovetz L, Jager W, Dietrich H, Plank C. Aromatherapy: evidence for sedative effects of the essential oil of lavender after inhalation. Z Naturforsch C. 1991; 46:1067-1072.
46. Buckle J. Aromatherapy. Nurs Times. 1993;89:32-35.
48. Hardy M, Kirk-Smith MD, Stretch DD. Replacement of drug treatment for insomnia by ambient odour. Lancet 1995;346:701.
49. Hudson R. Nursing: the value of lavender for rest and activity in the elderly patient. Complement Ther Med. 1996;4:52-57.
53. Lehrner J, Marwinski G, Lehr S, Johren P, Deecke L. Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office. Physiol Behav. 2005;86:92-95.
54. Xu F, Uebaba K, Ogawa H, et al. Pharmaco-physio-psychologic effect of Ayurvedic oil-dripping treatment using an essential oil from Lavendula angustifolia. J Altern Complement Med. 2008;14(8):947-956.
55. Walsh E, Wilson C. Complementary therapies in long-stay neurology in-patients settings. Nurs Stand. 1999;13:32-35.
56. Alaoui-Ismaïli O, Vernet-Maury E, Dittmar A, Delhomme G, Chanel J. Odor hedonics: connection with emotional response estimated by autonomic parameters. Chem Senses. 1997;22(3):237-248.
57. Tysoe P. The effect on staff of essential oil burners in extended care settings. Int J Nurs Pract. 2000;6:110-112.
58. Diego MA, Jones NA, Field T, et al. Aromatherapy positively affects mood, EEG patterns of alertness, and math computations. Int J Neurosci. 1998;96:217-224.
59. Lewith GT, Godfrey AD, Prescott P. A single-blind, randomized pilot study evaluating the aroma of Lavandula angustifolia, as a treatment for mild insomnia. J Altern Complement Med. 2005;11(4):631-637.
60. Buckle J. Use of aromatherapy as a complementary treatment for chronic pain. Altern Ther Health Med 1999;5:42-51.
61. Bradley BF, Brown SL, Chu S, Lea RW. Effects of orally administered lavender essential oil on responses to anxiety-provoking film clips. Hum Psychopharmacol. 2009;24(4):319-330.
62. Kasper S, Gastpar M, Müller WE, et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol 2010;25:277-287.
63. Woelk H, Schlaefke S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine. 2010;17:94-99.
64. Azkhondzadeh S, Kashani L, Fotouhi A, et al. Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):123-127.
65. Stange R, Schaper S, Uehleke B, Dienel A, Schlaefke S. Phase II study on the effects of lavender oil (Silexan) in patients with neurasthenia, posttraumatic stress disorders or somatisation disorder. Focus on Alternative and Complementary Therapies. 2007;12:46.
66. Tisserand R. Lavender beats benzodiazepines. Int J Aromather. 1988;1:1-2.
67. Woelk H, Kapoula O, Lehr S, Schröter K, Weinholz P. A comparison of Kava special extract WS 1490 and benzodiazepines in patients with anxiety. Healthnotes Review. 1999;6:265-270.
69. Allgulander C, Hartford J, Russell J, et al. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials. Curr Med Res Opin. 2007;23(6):1245-1252.
70. Hidalgo RB, Tupler LA, Davidson JR. An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol. 2007;21:864-872.
71. Woelk H, Kapoula O, Lehr S, Schröter K, Weinholz P. A comparison of Kava special extract WS 1490 and benzodiazepines in patients with anxiety. Healthnotes Review. 1999;6:265-270.
73. Atanassova-Shopova S, Roussinov KS. On certain central neurotropic effects of lavender essential oil. Izv Inst Fiziol. 1970;13;69-77.
74. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. John Wiley & Sons, New York, 1996:339-342.
75. Henley DK, Lipson N, Korach KS, Bloch CA. Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med. 2007;356:479-485.